Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Informācija par akcionāru sapulcēm |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2017-05-02 17:56:22 |
Versijas komentārs | |
Teksts |
Report of the Supervisory Council of JSC „Olainfarm” to the General
Meeting of Shareholders
Supervisory Council of JSC „Olainfarm” has read the Consolidated
and Parent Company’s Annual reports for 2016, as well as
Independent Auditors’ Report about it. In addition, the Council has
assessed financial position of the Company and Operations of the
Management Board during this financial year and hence produced this
Report.
The Council values the work conducted by Company’s Board during the
last year as satisfactory, because, although its operations allowed
the Company to significantly increase its sales in 2016, due to
several unfavorable decisions and conditions it had to make
significant provisions during this period, resulting in
considerable profit reduction. The Council highly appreciated the
acquisition of SIA Tonus Elast, which is so far the biggest
acquired daughter company of the Group. Tonus Elast is the
company with a very strong and clearly not fully realized export
potential. The Council urges the Board to closely follow that
during the harmonization of processes positions of Tonus Elast in
its existing markets are not harmed. With regard to other
acquisitions of 2016 and the upcoming ones, the Council asks the
Board to assess financial feasibility of such, especially if the
target operates in a sector where expertise of the Company itself
is very limited. The Council supports an opinion that for
more rapid growth the Company must rather focus on acquisition of a
larger company with greater development potential, than waste its
financial and other resources on smaller, riskier and
administratively more demanding objects.
Rapid decline in Company’s profitability and significant provisions
for doubtful receivables made in 2016 makes the Council to draw
Board’s attention to issues directly related to Company’s
profitability, specifically, to necessity to more carefully assess
the recoverability of assets and justification and transparency of
marketing and sales costs of Parent Company and daughter
companies. The Council fully appreciates that when entering
new markets or launching new products bigger sales and marketing
costs are unavoidable. However, the Council asks the Board to
be more critical regarding the necessity to bear significant
marketing costs for well-established products in well-established
countries.
During 2016 the Council continued following the development of
different companies in the Group. And this is the second year in a
row, when the Council wants to specifically emphasize rapid and
positive development of SIA Silvanols. 2016 has been the second
year in a row when this company makes significant profit from its
main operations. It is particularly satisfying that 2016 is
going to be the first year, when this company pays dividends to its
shareholders from its profits gained that year.
The Council is satisfied that the Board is dedicated to solve the
related party lending issue and is suggesting the relatively high
dividend payments of 0.64 cents per share, making the payments in
three installments at the end of second, third and fourth quarters.
The Council shares Boards conservatism in approach to
Company’s liquidity this year, but would like to draw the attention
of the Board and shareholders that therefore suggests to abstain
from it.
During 2016 the Council of the Company has performed its duties and
supervised operations of the Company according to legislation,
decisions by the general meeting. The Council has approved
financial statements and overviewed operations of Company’s
management. During the reporting period 17 Council meetings
were held. During these meetings, Board reports, Board
composition, plans, planned and actual budgets were reviewed.
Agenda items of general meeting was pre-approved. Council found no
significant insufficiencies in Boards operations in 2016. The
Board has been in constant consultations with the Council and has
taken into account all previously mentioned and other
recommendations of the Council targeted at safe further development
of the Company.
The Council would like to take
this opportunity to thank the Board, all employees of the Company
and its partners for cooperation in 2016, and to wish successful,
stable and positively challenging next year.
Approved by the Council Meeting on
April 28, 2017
Chairman of the
Council
Ivars Godmanis
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information prepared by:
|
Pielikumi |
|